trials
-
Molecular Profiles invests in new facility to increase manufacturing capabilities for clinical trials
Molecular Profiles, a leading specialist contract research and manufacturing organization, announces the commencement of construction of a new manufacturing facility. This £9 million investment will allow Molecular Profiles to expand its current manufacturing capabilities while strengthening its existing expertise in the drug development field.
trials | 19 January 2012
-
S*BIO to initiate global phase 3 clinical trials of its novel JAK2 inhibitor
S*BIO explores partnering opportunities for advancement of its JAK2 program.
trials | 25 October 2011
-
AstraZeneca and Forest Laboratories to initiate phase 3 clinical trials for ceftazidime/avibactam
Treatment for serious Gram-negative bacterial infections.
trials | 18 October 2011
-
Bi-axial bioreactor set to revolutionise pre-clinical trials in the field of regenerative medicine.
Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.
trials | 10 October 2011
-
First cancer drug developed in Singapore shows encouraging results in early human clinical trials
National University Cancer Institute, Singapore and the Cancer Science Institute of Singapore, NUS partner local biotechnology company S*BIO to further develop cancer drug, SB939.
trials | 16 March 2011
-
S*BIO Completes Patients Enrollment in Phase 2 Clinical Trials
S*BIO announces that it has completed enrollment of patients in two separate Phase 2 clinical trials for its potent and orally-active JAK2 inhibitor SB1518 at multiple clinical sites in the US and Australia for the treatment of myelofibrosis (MF). …
trials | 14 June 2010
-
World Pharma Trials Asia 2010
World Pharma Trials Asia was held from March 17-18, at the BioPharma Asia Convention 2010. It is an event convening pharmas, biotechs, and Contract Research Organizations (CROs) to explore offshoring and outsourcing opportunities in Asia for cost eff…
trials | 16 April 2010
-
Clinuvel to Commence US Patient Trials
An Australian drug to protect patients who are intolerant of light and sunlight will begin trials in the US. The US Food and Drug Administration (FDA) has given clearance to Melbourne’s Clinuvel Pharmaceuticals to commence a Phase II study (CUV030)…
trials | 07 April 2010
-
Icon Opens Office in the Philippines
Icon , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that it will expand its footprint in Asia Pacific with the opening of an office in Manila, Philippines. …
trials | 24 March 2010
-
CBio Receives Approvals for Rheumatoid Arthritis Trials
Australian-based drug development company CBio has announced a milestone achievement in its research in the treatment of rheumatoid arthritis. Jason Yeates, MD, said that human research ethics committee approvals have been received for all Centra…
trials | 18 March 2010
